The community speaks

Every year, our program includes keynote speeches by some of the top thinkers and trend-makers in pharma, biotech, medtech, digital health, investment & funding, regulatory.

NLSDays features company presentations organised into tracks that interest specific audiences and fields, for example: pharma and biotechnology in R&D, therapeutics or diagnostics, academic and startup innovators, services providers.

Super Sessions address hot topics in science, business development and market strategies.

In between all of these delightful speaking events, we make sure everyone is refreshed by a classic Swedish ‘fika’ – all that your heart desires, plus lots of coffee.

Ms. Niina Aagaard

Chief Operating Officer, Nordic Innovation

20 Apr 11:15 Super Session 1

Dr. Mervi Aavikko

Project Manager FinnGen, University of Helsinki

20 Apr 11:15 Super Session 1

Dr. Ingrid Teigland Akay

Managing Partner, Hadean Ventures

21 Apr 09:15 Super Session 4

Dr. Jacqueline Ameri

CEO, Pancryos

20 Apr 09:30 Opening Plenary

Dr. Sonia Benhamida

Senior Vice President Healthcare, DNB

21 Apr 09:15 Super Session 4

Mr. Karl Bergman

CEO, Elypta

21 Apr 11:15 Super Session 5

Dr. Magnus Björsne

CEO, Astrazeneca BioVentureHub

21 Apr 13:45 Super Session 6

Ms. Jeanne Bolger

Corporate Venture Capital Investor, Johnson & Johnson Innovation

21 Apr 09:15 Super Session 4

Dr. Nikolai Brun

Chair HMA-EMA Taskforce on Big Data

20 Apr 11:15 Super Session 1

Dr. Dina Chaya

Partner, NeoMed Management - Advisor, Omega Funds

Ms. Karin Conde-Knape

CVP Global Diabetes, Cardio-Renal and Global Drug Discovery, Novo Nordisk

21 Apr 11:15 Super Session 5

Dr. Eric De La Fortelle

Venture Partner Seventure Partners

20 Apr 13:45 Super Session 2

Mr. Olivier Duchamp

Managing Director, NLSDays - NLS Invest

20 Apr 09:30 Opening Plenary

Dr. Falk Ehmann (TBC)

Chair Innovation Task Force, European Medicines Agency

21 Apr 11:15 Super Session 5

Mr. Bogi Eliasen

Director of Health, Copenhagen Institute for Futures Studies

20 Apr 11:15 Super Session 1

Mr. Erik Gatenholm

CEO and Co-Founder, Cellink

20 Apr 09:30 Opening Plenary

Dr. Gianfranco Grompone

Chief Scientific Officer, BioGaia

20 Apr 13:45 Super Session 2

Ms. Carolina Haefliger

VP, Head Centre for Genomics Research, AstraZeneca

21 Apr 11:15 Super Session 5

Dr. Deborah Harland

Partner at SR One - GSK Venture Capital Group

21 Apr 09:15 Super Session 4

Dr. Rafiq Hasan

CEO, ExACT Therapeutics

20 Apr 09:30 Opening Plenary

Dr. Jutta Heix

Head of International Affairs, Oslo Cancer Cluster - Super Session Chair

21 Apr 11:15 Super Session 5

Ms. Kaisa Helminen

Chief Operating Officer, Aiforia Technologies

20 Apr 09:30 Opening Plenary

Mr. Torbjörn Hägglöf

Artificial Intelligence Business Sales & Delivery Executive, Cognitive Business Solutions, IBM Global Business Services

21 Apr 13:45 Super Session 6

Dr. Frederik Knud Nielsen

Strategic Pipeline Lead, Nordics, Novartis

20 Apr 11:15 Super Session 1

Ms. Sarah Lidé

Senior Strategy & Project Manager, Medicon Valley Alliance

20 Apr 13:45 Super Session 2

Mr. Emmanuel Ligner

CEO & President at Cityva (former GE Healthcare Life Sciences)

20 Apr 09:30 Opening Plenary

Dr. Elisabeth Liljensten

CEO, Devicia

21 Apr 13:45 Super Session 6

Dr. Lars Lindsköld

Portfolio manager, Sweper / Swelife

20 Apr 11:15 Super Session 1

Dr. Joanne M. Hackett

General Partner Healthcare, IZY Capital

21 Apr 09:15 Super Session 4

Ms. Rajji Mehdwan

General Manager, Roche Norway

20 Apr 11:15 Super Session 1

Dr. Mirjam Mol-Arts

Chief Science and Medical Officer, Ferring Pharmaceuticals

20 Apr 13:45 Super Session 2

Dr. Henrik Bjørn Nielsen

Chief Scientific Officer, Clinical Microbiomics

20 Apr 13:45 Super Session 2

Ms. Sofia Nordgren

Director of Regulatory Affairs, Devicia

21 Apr 13:45 Super Session 6

Dr. Sam Oddsson

Chief Medical Officer & Co-Founder, SidekickHealth

21 Apr 13:45 Super Session 6

Mr. Martin Olovsson

CEO and Co-Founder, Ondosis

21 Apr 13:45 Super Session 6

Ms. Felicitas Riedl

Life Science Expert, European Investment Bank

21 Apr 09:15 Super Session 4

Ms. Louise Rosenlund Nielsen

Head of International Development & Partnerships, CopCap

20 Apr 11:15 Super Session 1

Dr. Paul Ross

Director, APC Microbiome Ireland

20 Apr 13:45 Super Session 2

Dr. Jessica Shull

European Lead, Digital Therapeutics Alliance

21 Apr 13:45 Super Session 6

Mr. Gudmundur Fertram Sigurjonsson

Founder, President & CEO, Kerecis

Dr. Patrick Sobocki

Investment Manager, Industrifonden

21 Apr 11:15 Super Session 5

Ms. Helena Strigård

Director General, SwedenBIO

20 Apr 09:30 Opening Plenary

Dr. Christina Trojel-Hansen

CEO and Co-Founder - Oscine Therapeutics, in Residence - Arch Venture Partners

21 Apr 09:15 Super Session 4

Dr. Gupta Udatha

Project Coordinator, DIGI-B-CUBE

21 Apr 11:15 Super Session 5